Table 3. Prognostic factors predicting overall disease-free survival in all patients with papillary thyroid carcinoma.
Variable | Univariate analysis | Multivariate analysis | ||
---|---|---|---|---|
p-value | HR | 95% CI | p-value | |
Age (≥ 45 years) | 0.070 | 0.674 | 0.323–1.407 | 0.294 |
Sex (male) | 0.310 | 0.924 | 0.398–2.145 | 0.854 |
Aggressive variant | 0.048 | 1.774 | 0.523–6.014 | 0.357 |
pT (T1-2 vs. T3-4) | 0.027 | 1.667 | 0.552–5.031 | 0.365 |
Lymph node metastasis | < 0.001 | 1.402 | 0.569–3.455 | 0.463 |
Lateral LN metastasis | < 0.001 | 3.690 | 1.824–7.465 | < 0.001 |
Dyscohesive cells | 0.031 | 1.731 | 0.655–4.580 | 0.269 |
Psammoma body | 0.022 | 1.819 | 0.826–4.005 | 0.138 |
BRAF V600E mutation | 0.872 | 0.978 | 0.386–2.477 | 0.962 |
Aggressive variants included 21 tall cell variants and 1 hobnail variant. Presence of dyscohesive cells in ≥ 1% of the tumor periphery and invasive front was categorized as positive. Presence of psammoma body was considered as positive when its number was more than 3. LN, lymph node.